Plant Variety Rights

(PVRs)

Experts in IP Protection for Plant Variety Inventions


Improvement of crop and ornamental species by genetic modification or modern breeding techniques remains a significant area of innovation. A number of IP rights may be suitable for protecting plant inventions, including patents, trade marks, plant Variety Rights (PVRs) and entry on the national list or common catalogue. Our experienced IP specialists are well placed to assist our clients in this area, having a wealth of practical experience.

In Europe, individual plant varieties that are distinct, uniform and stable can be protected either nationally or at European Community level. Separately, European and national patents can be obtained for plants and plant-related inventions which are not restricted to plant varieties per se, although certain plant breeding methods and plants obtained by those methods are excluded from patentability.  Despite the EU’s strict policies on growing genetically modified crops and uncertainty surrounding the use of genetic resources in plant breeding, there is considerable commercial interest in these technical areas and in IP protection for the output of biotech research and classical breeding programs.

Our expert IP team is led by Frances Salisbury, who has a PhD in plant molecular genetics. An expert in this field Frances has completed the official World Intellectual Property Organisation (WIPO) course on Plant Variety Protection under the UPOV Convention.

Read our Plant Variety Rights Law and Practice guide.

Read our blogs

EPO decision T 0655/24: Striking the Right Balance in Antibody Claim Drafting

EPO decision T 0655/24: Striking the Right Balance in Antibody Claim Drafting

by Chris Denison

This is the second in a series of three posts on recent decision T 0655/24 and its implications for antibody practice at the EPO.

FA Bio: unlocking the secrets of soil microbiome

FA Bio: unlocking the secrets of soil microbiome

by Louise Atkins

Forward speaks to Ángela de Manzanos Guinot, founder of FA Bio, about how they are replacing harsh agricultural chemicals with naturally occurring fungi which work in harmony with agricultural soils, ...

Medical Technologies: From Concept to Patient Care

Medical Technologies: From Concept to Patient Care

by Andrew Mears

On Tuesday 3 June 2026, we were delighted to host our in-person panel discussion and networking event ‘Medical Technologies: From Concept to Patient Care’, bringing together key voices from across ...

“AI” in Bioprocessing – What’s Behind the Buzzword?

“AI” in Bioprocessing – What’s Behind the Buzzword?

by Anja Koller

At the 2026 Global Bioprocessing & Biotechnology Summit in Berlin, “AI” was a hot topic – from media development and enzyme screening to manufacturing, clinical data analysis and supply chain ...

Daya Ventures: The startup factory closing the gender health gap

Daya Ventures: The startup factory closing the gender health gap

by Frances Salisbury

Forward speaks to Daya Venture's CCO, Victorine Lançon as she tells Mewburn Ellis why 16 startups are just the beginning of a mission to improve women's healthcare in the most hands-on way possible.

EPO decision T 0655/24: A Strict Stance on Post-Filing Evidence

EPO decision T 0655/24: A Strict Stance on Post-Filing Evidence

by Chris Denison

Recently issued EPO decision T 0655/24 will be of great interest to those following antibody patenting at the EPO. It deals with several recurring themes, particularly around inventive step and ...

ME Forward Masthead White 2